[1]李玄丹,李材忠,唐永婕,等.老年ARDS 患者血清FGF-21，GDF-15 及PTX-3 表达水平及其与病情评估和预后的相关性研究[J].现代检验医学杂志,2022,37(04):188-192.[doi:10.3969/j.issn.1671-7414.2022.04.037]
　LI Xuan-dan,LI Cai-zhong,TANG Yong-jie,et al.Expression Levels of Serum FGF-21, GDF-15 and PTX-3 in Elderly Patients with ARDS and Their Correlation with Disease Evaluation and Prognosis[J].Journal of Modern Laboratory Medicine,2022,37(04):188-192.[doi:10.3969/j.issn.1671-7414.2022.04.037]
点击复制

老年ARDS 患者血清FGF-21，GDF-15 及PTX-3 表达水平及其与病情评估和预后的相关性研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第37卷
期数:
2022年04期
页码:
188-192
栏目:
检验与临床
出版日期:
2022-07-15

文章信息/Info

Title:
Expression Levels of Serum FGF-21, GDF-15 and PTX-3 in Elderly Patients with ARDS and Their Correlation with Disease Evaluation and Prognosis
文章编号:
1671-7414（2022）04-188-05
作者:
李玄丹; 李材忠; 唐永婕; 蔡萧阳
儋州市人民医院呼吸内科 , 海南儋州 571179
Author(s):
LI Xuan-dan;  LI Cai-zhong;  TANG Yong-jie;  CAI Xiao-yang
Department of Respiratory，Danzhou People’s Hospital，Hainan Danzhou 571799，China
关键词:
急性呼吸窘迫综合征; 成纤维细胞生长因子21; 生长分化因子15; 正五聚蛋白3
分类号:
R563.8；R392.11
DOI:
10.3969/j.issn.1671-7414.2022.04.037
文献标志码:
A
摘要:
目的 探讨血清成纤维细胞生长因子21（fibroblast growth factor 21,FGF-21）、生长分化因子15（growthdifferentiation factor 15 ,GDF-15）及正五聚蛋白3（pentamerin 3,PTX-3） 水平对老年急性呼吸窘迫综合征（acuterespiratory distress syndrome，ARDS）患者病情评估及预后预测的价值。方法 选取2019 年1 月～ 2021 年12 月儋州市人民医院收治的125 例老年ARDS 患者，根据氧合指数（oxygenation index ,OI）将老年ARDS 患者分为轻度组(n=32)、中度组(n=53) 和重度组(n=40)，根据入重症监护室（intensive care unit，ICU）30 天内的生存情况将老年ARDS 患者分为存活组(n=76) 和死亡组(n=49)。检测老年ARDS 患者发病当天血清FGF-21，GDF-15 及PTX-3 水平。应用多因素Logistic 回归分析影响老年ARDS 患者死亡的危险因素，绘制ROC 曲线分析血清FGF-21，GDF-15 及PTX-3 水平对老年ARDS 患者预后预测的价值。相关性分析采用Pearson 相关。结果 死亡组血清FGF-21（3 268.37±456.27 pg/ml），GDF-15（3 605.20±419.35 pg/ml） 及PTX-3（27.15±8.72ng/ml） 水平均明显高于存活组（950.24±130.28pg/ml，1 468.15±247.30 pg/ml，13.40±4.16 ng/ml），差异有统计学意义（t =17.361, 16.240，14.802，均P ＜ 0.001）。重度组血清FGF-21（3 709.24±524.17 pg/ml），GDF-15（4 150.83±507.42 pg/ml）及PTX-3（31.28±10.26 ng/ml）水平均明显高于中度组（2 587.60±347.25 pg/ml，2 889.25±385.26 pg/ml，19.45±5.83 ng/ml）和轻度组（621.38±103.14 pg/ml，1 007.36±194.12 pg/ml，11.27±2.90 ng/ml），差异有统计学意义（F =20.153, 18.216, 17.615，均P ＜ 0.001）。多因素Logistic 回归分析显示，OI 低（OR=2.375, 95%CI:1.502~5.113），APACHE Ⅱ评分(OR=2.803, 95%CI:1.985~6.926)，SOFA 评分(OR=1.716, 95%CI:1.208~3.412)，FGF-21(OR=3.205, 95% CI:2.647~9.683)，GDF-15(OR=2.490, 95%CI:1.712~5.770) 及PTX-3(OR=3.104, 95%CI:2.573~9.184) 水平升高是影响ARDS 患者死亡的危险因素（均P ＜ 0.05）。ROC 曲线显示，FGF-21，GDF-15 及PTX-3 三项联合预测老年ARDS 患者死亡的AUC 最大（0.957，95%CI：0.897 ～ 0.998）。相关分析显示，ARDS 死亡患者血清FGF-21 水平与GDF-15，PTX-3 均呈正相关（r=0.842, 0.870, 均P ＜ 0.001）。结论 血清FGF-21，GDF-15 及PTX-3 水平升高与老年ARDS 患者病情较重和死亡有关，三项联合检测能较好地预测老年ARDS 患者的预后。
Abstract:
Objective To investigate the value of levels of serum fibroblast growth factor-21 (FGF-21), growth differentiation factor-15 (GDF-15) and N-pentamerin 3 (PTX-3) in evaluating the condition and predicting the prognosis of elderly patients with acute respiratory distress syndrome (ARDS). Methods 125 elderly patients with ARDS treated in Danzhou People’s Hospital from January 2019 to December 2021 were selected. According to the oxygenation index (OI), the elderly patients with ARDS were divided into 32 mild groups, 53 moderate groups and 40 severe groups. According to the survival situation within 30 days after entering the intensive care unit, the elderly patients with ARDS were divided into 76 survival group and 49 death group. The levels of serum FGF-21, GDF-15 and PTX-3 in elderly patients with ARDS were detected on the day of onset. Multivariate logistic regression was used to analyze the risk factors of death in elderly patients with ARDS, and ROC curve was drawn to analyze the value of serum FGF-21, GDF-15 and PTX-3 levels in predicting the prognosis of elderly patients with ARDS. Pearson correlation was used for correlation analysis. Results The levels of serum FGF-21（3 268.37±456.27 pg/ml）， GDF-15（3 605.20±419.35 pg/ml）and PTX-3（27.15±8.72ng/ml）in the death group were significantly higher than those in the survival group，the differences were statistically significant（t =17.361，16.240，14.802， all P ＜ 0.001）. The levels of serum FGF-21（3 709.24±524.17 pg/ml），GDF-15（4 150.83±507.42 pg/ml）and PTX-3（31.28±10.26 ng/ml） in severe group were significantly higher than those in moderate group（2 587.60±347.25 pg/ml，2 889.25±385.26 pg/ml， 19.45±5.83 ng/ml）and mild group（621.38±103.14 pg/ml，1 007.36±194.12 pg/ml，11.27±2.90 ng/ml），the differences were statistically significant（F =20.153,18.2165,17.615，all P ＜ 0.001）. Multivariate logistic regression analysis showed that low OI（OR=2.375,95%CI:1.502~5.113）, Apache Ⅱ score(OR=2.803, 95% CI:1.985~6.926), SOFA score(OR=1.716, 95%CI:1.208~3.412), elevated levels of FGF-21(OR=3.205, 95% CI:2.647~9.683), GDF-15(OR=2.490, 95%CI:1.712~5.770) and PTX-3(OR=3.104, 95%CI:2.573~9.184) were the risk factors of death in patients with ARDS (all P<0.05). ROC curve showed that the combination of FGF-21, GDF-15 and PTX-3 had the highest AUC in predicting death of elderly patients with ARDS (0.957, 95%CI: 0.897 ～ 0.998). Correlation analysis showed that the level of serum FGF-21 in death patients with ARDS were positively correlated with GDF-15 and PTX-3 (r=0.842, 0.870, all P ＜ 0.001). Conclusion The increase of serum FGF- 21, GDF-15 and PTX-3 levels is related to the severity and death of elderly patients with ARDS, and the combination of the three can better predict the prognosis of elderly patients with ARDS.

参考文献/References:

[1] JAGATHKAR G. Acute respiratory distress syndrome in the elderly[J]. Indian Journal of Critical Care Medicine, 2021, 25(6): 613-614.
[2] EBRAHIMI F, WOLFFENBUTTEL C, BLUM C A,et al. Fibroblast growth factor 21 predicts outcome in community-acquired pneumonia: secondary analysis of two randomised controlled trials[J]. The European Respiratory Journal, 2019, 53(2): 1800973.
[3] SKOWRO?SKA M, SKRZY?SKA M, MACHOWSKI M, et al. Plasma growth differentiation factor 15 levels for predicting serious adverse events and bleeding in acute pulmonary embolism: a prospective observational study[J]. Polish Archives of Internal Medicine, 2020,130(9): 757-765.
[4] GEN? A B, YAYLACI S, DHEIR H, et al. The predictive and diagnostic accuracy of long pentraxin-3 in COVID-19 pneumonia[J]. Turkish Journal of Medical Sciences, 2021, 51(2): 448-453.
[5] RANIERI V M, RUBENFELD G D, THOMPSON B, et al. Acute respiratory distress syndrome the Berlin definition[J]. Journal of the American Medical Association, 2012, 307(23): 2526-2533.
[6] TORRES L K, HOFFMAN K L, OROMENDIA C, et al. Attributable mortality of acute respiratory distress syndrome: a systematic review, meta-analysis and survival analysis using targeted minimum loss-based estimation[J]. Thorax, 2021, 76(12): 1176-1185.
[7] GAO Jing, LIU Qiuhong, LI Junlu, et al. Fibroblast growth factor 21 dependent TLR4/MYD88/NF-κB signaling activation is involved in lipopolysaccharideinduced acute lung injury[J]. International Immunopharmacology, 2020, 80: 106219.
[8] SONG Hengya, CHEN Qian, XIE Songping, et al.GDF-15 prevents lipopolysaccharide-mediated acute lung injury via upregulating SIRT1[J]. Biochemical and Biophysical Research Communications, 2020, 526(2):439-446.
[9] PROTTI A, MEESSEN J, BOTTAZZI B, et al.Circulating pentraxin 3 in severe COVID-19 or other pulmonary sepsis[J]. European Journal of Clinical Investigation, 2021, 51(5): e13530.
[10] 张放, 郭树彬, 姬文卿, 等. 外周血成纤维细胞生长因子-21 在脓毒症及感染性休克中的表达[J]. 中国急救医学, 2020, 40(7): 644-648. ZHANG Fang, GUO Shubin, JI Wenqing, et al.Expression of plasma FGF-21 in sepsis and septic shock [J]. Chinese Journal of Critical Care Medicine,2020, 40 (7): 644-648.
[11] ROSENBERG B J, HIRANO M, QUINZII C M, et al. Growth differentiation factor-15 as a biomarker of strength and recovery in survivors of acute respiratory failure[J]. Thorax, 2019, 74(11): 1099-1101.
[12] 赵涛, 杨华, 向薇, 等. 血清PTX3, Gal-3 表达水平对老年急性呼吸窘迫综合征患者预后的评估价值[J]. 疑难病杂志, 2021, 20(12):1210-1214,1219. ZHAO Tao, YANG Hua, XIANG Wei, et al. Prognostic value of serum PTX3 and Gal-3 expression levels in elderly patients with acute respiratory distress syndrome[J]. Chinese Journal of Difficult and Complicated Cases, 2021, 20 (12): 1210-1214, 1219.
[13] SEHGAL I S, AGARWAL R, DHOORIA S, et al. Risk stratification of acute respiratory distress syndrome using a PaO2: Fio2 threshold of 150 mmHg: A retrospective analysis from an Indian intensive care unit[J]. Lung India, 2020, 37(6): 473-478.
[14] YOO J W, JU Sunmi, LEE S J, et al. Geriatric nutritional risk index is associated with 30-day mortality in patients with acute respiratory distress syndrome[J]. Medicine, 2020, 99(25): e20671.
[15] 尚明升, 高延秋, 贾宝辉, 等. 生长分化因子-15 和血管外肺水指数在ARDS 患者严重程度分级及预后预测中的价值[J]. 中华危重病急救医学, 2020,32(10): 1226-1230. SHANG Mingsheng, GAO Yanqiu, JIA Baohui, et al. The value of growth differentiation factor-15 and extravascular lung water index in severity grading of acute respiratory distress syndrome patients and their prognosis prediction [J]. Chinese Critical Care Medicine, 2020,32 (10): 1226-1230.
[16] LI Xing, SHEN Hua, ZHOU Tinghong, et al. Does an increase in serum FGF21 level predict 28-day mortality of critical patients with sepsis and ARDS[J].Respiratory Research, 2021, 22(1): 182.
[17] 常东歌, 袁咏梅, 张庆, 等．急性呼吸窘迫综合征患者血浆正五聚体素-3 的表达水平及对预后评估的价值[J]．热带医学杂志, 2020, 20（5）：658-662. CHANG Dongge, YUAN Yongmei, ZHANG Qing, et al. Expression of plasma pentraxin 3 in patients with acute respiratory distress syndrome and its prognostic evaluation value [J]. Journal of Tropical Medicine,2020, 20 (5): 658-662.

相似文献/References:

[1]张 超,达 晶,杨 智,等.创伤性湿肺并发ARDS 纤溶患者血清中NF-KB p65表达的分析[J].现代检验医学杂志,2020,35(04):53.[doi:10.3969/j.issn.1671-7414.2020.04.013]
　ZHANG Chao,DA Jing,YANG Zhi,et al.Expression of Blood NF-KB p65 in Patients with Traumatic Wet Lung Complicated with ARDS Fibrinolysis[J].Journal of Modern Laboratory Medicine,2020,35(04):53.[doi:10.3969/j.issn.1671-7414.2020.04.013]
[2]闫海燕,杨云华,杨云秀,等.ARDS患者肺泡动脉氧分压差与死腔分数检测在病情判断和短期预后评估中的应用价值[J].现代检验医学杂志,2021,36(02):132.[doi:doi:10.3969/j.issn.1671-7414.2021.02.031]
　YAN Hai-yan,YANG Yun-hua,YANG Yun-xiu,et al.Application Value of Difference of Alveolar Arterial Oxygen Partial Pressure and Dead Volume Ratio in the ARDS Patients to Judge Disease Condition and Short-Term Prognosis Assessment[J].Journal of Modern Laboratory Medicine,2021,36(04):132.[doi:doi:10.3969/j.issn.1671-7414.2021.02.031]
[3]宋婷阁,张鹏举,耿　彪,等.新生儿急性呼吸窘迫综合征患者血清miR-183-5p的表达及与IL-1β，IL-6和TNF-α水平的相关性[J].现代检验医学杂志,2021,36(05):55.[doi:10.3969/j.issn.1671-7414.2021.05.012]
　SONG Ting-ge,ZHANG Peng-ju,GENG Biao,et al.Expression of Serum miR-183-5p in Patients with Neonatal Acute RespiratoryDistress Syndrome and Its Correlation with IL-1 β, IL-6 and TNF-α[J].Journal of Modern Laboratory Medicine,2021,36(04):55.[doi:10.3969/j.issn.1671-7414.2021.05.012]
[4]王庆妹,崔慧娟,杜京辉,等.外周血单个核细胞miRNA-492和miRNA-155水平表达与SNAPPE-Ⅱ评分对儿童急性呼吸窘迫综合征预后价值研究[J].现代检验医学杂志,2022,37(03):6.[doi:10.3969/j.issn.1671-7414.2022.03.002]
　WANG Qing-mei,CUI Hui-juan,DU Jing-hui,et al.Study on the Prognostic Value of miRNA-492 and miRNA-155 Levels in Peripheral Blood Mononuclear Cells and SNAPPE- Ⅱ Score in Children with Acute Respiratory Distress Syndrome[J].Journal of Modern Laboratory Medicine,2022,37(04):6.[doi:10.3969/j.issn.1671-7414.2022.03.002]
[5]张 云.脓毒症并发急性呼吸窘迫综合征患者血清SDC-1 的水平表达及其临床意义[J].现代检验医学杂志,2022,37(05):123.[doi:10.3969/j.issn.1671-7414.2022.05.024]
　ZHANG Yun.Expression of SDC-1 in Serum of Patients with Sepsis Associated Acute Respiratory Distress Syndrome and Its Clinical Significance[J].Journal of Modern Laboratory Medicine,2022,37(04):123.[doi:10.3969/j.issn.1671-7414.2022.05.024]
[6]朱 磊a,徐妍妍a,盛利平a,等.手足口病患儿血清FGF-21 与GDF-15 水平检测的临床诊疗应用研究[J].现代检验医学杂志,2023,38(05):180.[doi:10.3969/j.issn.1671-7414.2023.05.034]
　ZHU Leia,XU Yanyana,SHENG Lipinga,et al.Research on the Application of Serum FGF-21 and GDF-15 in Clinical Diagnosis and Treatment of Children with Hand, Foot and Mouth Disease[J].Journal of Modern Laboratory Medicine,2023,38(04):180.[doi:10.3969/j.issn.1671-7414.2023.05.034]
[7]余海波,孟 莉,彭 飞,等.急性呼吸窘迫综合征患者血清α1- 抗胰凝乳蛋白酶和α1- 抗胰蛋白酶表达水平及临床意义[J].现代检验医学杂志,2023,38(06):159.[doi:10.3969/j.issn.1671-7414.2023.06.029]
　YU Haibo,MENG Li,PENG Fei,et al.Serum Alpha-1-Antichymotrypsin and Alpha-1-Antitrypsin Expression Levels in Patients with Acute Respiratory Distress Syndrome and the Clinical Significance[J].Journal of Modern Laboratory Medicine,2023,38(04):159.[doi:10.3969/j.issn.1671-7414.2023.06.029]

备注/Memo

备注/Memo:
作者简介：李玄丹（1983-），女，本科，主治医师，主要从事呼吸疾病诊治研究，E-mail：Lxd4708@163.com。
更新日期/Last Update: 1900-01-01